Vanguard Health Care Fund Investor Shares (VGHCX) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.70: the stock has moved about 30% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerVanguard Health Care Fund Investor Shares (VGHCX) trades at $204.46. Vanguard Health Care Fund Investor Shares (VGHCX) provides investors with exposure to the health care industry through investments in pharmaceutical, medical supply, and research companies. Sector: Financials.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for VGHCX: VGHCX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Vanguard Health Care Fund Investor Shares (VGHCX) Financial Services Profile
Vanguard Health Care Fund Investor Shares (VGHCX) is an actively managed fund providing low-cost exposure to the healthcare sector, including pharmaceutical, medical supply, and research firms. With a focus on geographical diversification and lower turnover, VGHCX offers a complementary investment option for diversified portfolios seeking long-term growth within the healthcare industry.
What Is the Investment Thesis for VGHCX?
Vanguard Health Care Fund Investor Shares (VGHCX) presents a focused investment opportunity within the healthcare sector. The fund's key value driver is its low-cost structure, providing investors with efficient access to a diversified portfolio of healthcare companies. With a beta of 0.70, VGHCX exhibits lower volatility compared to the broader market, potentially offering a more stable investment option. Growth catalysts include the ongoing demand for healthcare services driven by aging populations and advancements in medical technology. The fund's emphasis on geographical diversification further enhances its growth potential by tapping into healthcare markets worldwide. However, investors should be aware of the fund's narrow focus on the healthcare sector, which exposes it to sector-specific risks and potential underperformance relative to broader market indices. The fund's long-term success hinges on its ability to navigate the evolving healthcare landscape and capitalize on emerging opportunities while maintaining its low-cost advantage.
Based on FMP financials and quantitative analysis
VGHCX Key Highlights
Market Cap of $40.19B indicating substantial investment in the healthcare sector.
- Beta of 0.70 suggesting lower volatility compared to the broader market, offering a potentially more stable investment.
- Actively managed fund providing investors with expert selection of healthcare companies.
- Focus on geographical diversification mitigating risk by spreading investments across different regions and healthcare systems.
- Low turnover strategy reducing transaction costs and potentially leading to greater tax efficiency for investors.
Who Are VGHCX's Competitors?
VGHCX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MIEIX MFS Institutional International Equity Fund | $42.34 | +0.55% | $27.7B | — |
| PREIX T. Rowe Price Equity Index 500 Fund | $200.39 | +0.74% | $41.0B | — |
| PRWCX T. Rowe Price Capital Appreciation Fund | $38.65 | +0.34% | $39.8B | — |
| RBHEX American Funds 2050 Target Date Retirement Fund | $25.35 | +0.96% | $42.7B | — |
| RRMGX T. Rowe Price Mid-Cap Growth Fund | $88.02 | +1.63% | $29.8B | — |
| BLK BlackRock, Inc. | $1066.45 | +0.64% | $165B | 51 5-pillar |
| BX Blackstone Inc. | $112.52 | +0.69% | $136B | 68 5-pillar |
| APOS Apollo Global Management, Inc. | $25.59 | 0.00% | $74.8B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are VGHCX's Key Strengths?
Low-cost structure
- Geographical diversification
- Lower turnover rate
- Experienced management team
What Are VGHCX's Weaknesses?
Narrow focus on the healthcare sector
- Potential for sector-specific risks
- Dependence on the performance of healthcare companies
- No dividend yield
What Are the Key Risks for VGHCX?
Regulatory changes in the healthcare industry impacting profitability.
- Economic downturn affecting healthcare spending and investment returns.
- Increased competition from other healthcare funds.
- Sector-specific risks associated with the healthcare industry.
- Patent expirations and generic competition impacting pharmaceutical company revenues.
What Are VGHCX's Competitive Advantages?
- Low-cost structure attracting cost-conscious investors.
- Geographical diversification mitigating risk and enhancing growth potential.
- Lower turnover rate reducing transaction costs and improving tax efficiency.
- Established reputation of Vanguard as a trusted investment manager.
What Does VGHCX Do?
Vanguard Health Care Fund Investor Shares (VGHCX) has been providing investors access to the healthcare sector for over 25 years. The fund operates as an actively managed investment vehicle, focusing on companies involved in various facets of the healthcare industry. These include pharmaceutical firms developing and manufacturing drugs, medical supply companies producing equipment and devices, and research firms engaged in advancing medical knowledge and technologies. VGHCX distinguishes itself through its commitment to low-cost investing, making it an accessible option for a wide range of investors. The fund's investment strategy emphasizes geographical diversification, seeking opportunities in both domestic and foreign markets. This approach aims to mitigate risk by spreading investments across different regions and healthcare systems. Furthermore, VGHCX maintains a lower portfolio turnover rate compared to many other healthcare funds. This strategy reduces transaction costs and can lead to greater tax efficiency for investors. While VGHCX offers targeted exposure to the healthcare sector, its narrow focus means returns can fluctuate significantly from year to year. As such, it is best suited as a component of a well-diversified portfolio with a long-term investment horizon. The fund is managed by Vanguard, a well-established investment management firm known for its commitment to low-cost investing and investor-focused principles.
What Products and Services Does VGHCX Offer?
- Invests in a diversified portfolio of healthcare companies.
- Focuses on pharmaceutical firms, medical supply companies, and research firms.
- Offers low-cost exposure to the healthcare sector.
- Emphasizes geographical diversification in its investments.
- Maintains a lower portfolio turnover rate compared to other healthcare funds.
- Actively manages the fund to achieve its investment objectives.
- Provides investors with access to the growth potential of the healthcare industry.
How Does VGHCX Make Money?
- Generates revenue through management fees charged to investors.
- Invests in a portfolio of healthcare companies.
- Seeks to provide long-term capital appreciation for its investors.
What Industry Does VGHCX Operate In?
Vanguard Health Care Fund Investor Shares (VGHCX) operates within the asset management industry, specifically focusing on the healthcare sector. The healthcare industry is experiencing growth driven by factors such as aging populations, increasing prevalence of chronic diseases, and advancements in medical technology. The competitive landscape includes other healthcare-focused funds such as MIEIX, PREIX, PRWCX, RBHEX, and RRMGX, each with its own investment strategy and risk profile. VGHCX differentiates itself through its low-cost structure, geographical diversification, and lower turnover rate, appealing to investors seeking efficient and diversified exposure to the healthcare market.
Who Are VGHCX's Key Customers?
- Individual investors seeking exposure to the healthcare sector.
- Institutional investors looking for diversified healthcare investments.
- Retirement savers seeking long-term growth in the healthcare industry.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 42 snapshots
| 2026-08-23 | 44 |
| 2026-08-31 | 44 |
| 2026-09-08 | 44 |
| 2026-09-16 | 44 |
| 2026-09-24 | 44 |
| 2026-10-04 | 44 |
| 2026-10-05 | 44 |
What changed?
The score has stayed at 44.
Over the same 30 days the stock moved -5.0%.
VGHCX Financials
Bull Case vs Bear Case
Bull Case
- Low-cost structure
- Geographical diversification
- Lower turnover rate
- Experienced management team
Bear Case
- Narrow focus on the healthcare sector
- Potential for sector-specific risks
- Dependence on the performance of healthcare companies
- No dividend yield
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
VGHCX Latest News
No recent news available for VGHCX.
VGHCX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for VGHCX.
Price Targets
Wall Street price target analysis for VGHCX.
VGHCX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for VGHCX; grades run from A+ (80-100) to F (below 30).
Common Questions About VGHCX (Financials)
What are the key performance indicators (KPIs) that Vanguard uses to measure the success of VGHCX?
Vanguard employs several key performance indicators (KPIs) to assess the success and effectiveness of VGHCX. These include the fund's total return compared to its benchmark index, the expense ratio relative to its peers, and the fund's tracking error, which measures how closely it follows its benchmark.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The information provided is based on available data and should not be considered investment advice.
- Investors should conduct their own research and consult with a financial advisor before making any investment decisions.